Supra Pacific Financial Services Limited

Financial Services — Credit Services · BSE

₹34.85+₹0.17 (+0.49%)

DalalBaazaar Score

73 / 100

🟢 Good

Verdict

NEUTRAL

Risk

Moderate

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:47 pm

Understanding the Business

Company site ↗

The 60-second version of Supra Pacific Financial Services Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Supra Pacific Financial Services Limited operates as a non-banking finance company in India. The company offers fund-based services, including two-wheeler loans, gold loans, and micro-finance services.

IndustryCredit Services

SectorFinancial Services

Employees735

Annual revenue₹88 Cr

How does it make money?

Turns over ₹88 Cr a year. Of every ₹100 of sales, about ₹9 reaches shareholders as profit, with ₹19 left at the operating level before interest, tax and depreciation. Each of its 735 employees supports ₹12.0 lakh of revenue a year, the signature of a people-led business.

Revenue / employee₹12.0 lakh

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, STATE BANK OF INDIA, HDFC BANK LTD, ICICI BANK LTD.. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

Peer median ROE16.5%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +625% while net margin moved +321% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+625%

Margin effect+321%

DalalBaazaar Score

73/ 100

Good

Weighted across six categories. Every point is explained below.

✓ Beta of -0.04 — historically steadier than the index
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Trading within 10% of its 52-week high — entries here carry more pullback risk
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

74/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

77/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

12.4x

3Y Median

80.8x

40 monthly readings · mean 84.3x · range 20.1x–137.9x

Sector Median

17.0x

median of 4 sector peers

🟢Current valuation is approximately 85% below its 3y median of 80.8x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 27% below the peer median of 17.0x.

vs. its own history

Cheap

80.8x median over 40 months · -85%

vs. sector peers

Cheap

17.0x median of 4 peers · -27%

vs. generic bands

Cheap

Below 15x

EV/EBITDA

28.7x

PEG

0.06

What's Good / What's Bad

🟢 What's Going Well2

Return on equity is rising
ROE has improved from 1.2% to 6.7%.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

2 items require attention · 2 watch

🟡Margins are compressingFinancial
EBITDA margin is down 2.1 points over 3 years.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 271% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 85% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 27% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 21.5% to 19.4%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 70% a year✓ 93.6% CAGR
Latest reported year was 22.7%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 17%✓ 19.4%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Return on equity stays above 8%✗ 6.7%
For a lender this is the cleanest single read on whether the book is being grown profitably.
4Interest cover stays above 4x✓ 4.8x
How much operating profit can fall before interest stops being comfortably covered.
5Valuation vs its own median of 80.8x✓ 12.4x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

5 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✗ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✗ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

5 good · 2 neutral · 4 weak

Market Cap

₹171 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

12.4x

Cheap

Cheap against the generic band

P/B Ratio

0.90x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹2.8

Profitable

Profitable on a per-share basis

ROE

6.7%

Weak

Weak capital efficiency

ROCE

2.5%

Weak

Low return on total capital employed

Debt/Equity

3.09x

High

High leverage

Revenue Growth (YoY)

22.7%

Healthy

Healthy top-line growth

Profit Growth (YoY)

94.9%

Healthy

Profits growing at a healthy clip

Dividend Yield

1.12%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹121 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

Operating Margin

20.5%

Good

Healthy core-business profitability

Net Margin

16.8%

Good

Strong bottom-line conversion

Current Ratio

8.99

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

-0.04

Defensive

Steadier than the market

52W Range Position

92%

Near high

Near its 52-week high

Technical Snapshot

SMA 20 / SMA 50

33.0 / 33.4

Bearish alignment (short < long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

54.7

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹12 Cr	₹26 Cr	₹48 Cr	₹88 Cr	+93.6%
EBITDA	₹3 Cr	₹5 Cr	₹8 Cr	₹17 Cr	+87.0%
EBITDA Margin	21.5%	17.9%	16.5%	19.4%	—
PAT (Net Profit)	₹0 Cr	₹1 Cr	₹1 Cr	₹8 Cr	+212.7%
EPS	₹0.23	₹0.38	₹0.37	₹1.6	+90.4%
ROE	1.2%	1.3%	1.8%	6.7%	—
ROCE	1.5%	1.1%	1.1%	2.5%	—
Total Debt	₹58 Cr	₹106 Cr	₹230 Cr	₹363 Cr	+84.0%
Free Cash Flow	-₹29 Cr	-₹68 Cr	-₹118 Cr	-₹121 Cr	—

🟢 Revenue has grown at 93.6% a year over 3 years.

🟢 EBITDA has grown at 87.0% a year over 3 years.

🔴 EBITDA Margin has fallen from 21.5% to 19.4% over 3 years (-2.1 pts).

🟢 PAT (Net Profit) has grown at 212.7% a year over 3 years.

🟢 EPS has grown at 90.4% a year over 3 years.

🟢 ROE has risen from 1.2% to 6.7% over 3 years (+5.5 pts).

🟡 ROCE has held roughly flat at 2.5% over 3 years.

🔴 Total Debt has grown at 84.0% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹493 Cr

Total Liabilities

₹375 Cr

Cash & Equivalents

₹41 Cr

Operating Cash Flow

-₹66 Cr

Capex

-₹55 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

61.6%

Corporate Actions

Dividend Rate

₹0.39

Ex-Dividend Date

21 Nov 2025

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
STATE BANK OF INDIA	10.3x	15.2%
HDFC BANK LTD	15.9x	13.8%
ICICI BANK LTD.	18.1x	16.5%

Recent News

3 mixed3 general

Supra Pacific Financial Services Share Price rises 8.42%

Univest, 22 SeptPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Supra Pacific Q2FY27 Results: Loan book reaches ₹418 crore, disbursements hit ₹305 crore

scanx.trade, 07 OctResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Supra Pacific Financial Services Ltd. Share Price Live Today

CNBC TV18, 03 Jan

Supra Pacific Financial Services (SUPRAPFSL) Share Price Falls 8.96% to Rs 30.90

Univest, 18 SeptPrice move

🟡Mixed / dependsA price move rather than a change in the business. If the figures on this page have not moved, the fall is either an opportunity or news they have yet to catch up with.

COMFINTE Stock Price and Chart — NSE:COMFINTE

TradingView, 20 Apr

Supra Pacific shareholders approve ₹1,500 crore borrowing limit

scanx.trade, 23 Sept

Watch Items

Trading very close to its 52-week high — momentum-driven entries here carry more mean-reversion risk.
This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Growth · Valuation

MiddlingProfitability

WeakRisk

Points for each in the Score ↑

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last.

1 of 5 tripwires tripped — Return on equity stays above 8% · see Key things to watch ↑